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AbstrACt
Objectives We looked at subjective attitude towards 
active surveillance (AS) as the first option for cancer 
management in a cohort of patients seeking first medical 
help for uroandrological disorders prior to a formal 
discussion with a caregiver.
Design Cross-sectional observational study.
setting Uroandrological outpatient clinic of a European 
academic centre.
Participants Data of 1059 patients at their first access for 
uroandrological purposes from January 2014 to December 
2016 were analysed.
Intervention Patients were invited to complete a survey 
with closed questions investigating their attitude towards 
AS, prior to any clinical evaluation. Likewise, patients were 
invited to score the importance given to different aspects 
of personal life in the case of a cancer diagnosis, using a 
10-point Likert scale.
Primary and secondary outcomes measures The 
reported opinion towards AS management for cancer was 
assessed. Logistic regression analyses tested participants’ 
sociodemographic characteristics associated with a 
positive opinion on AS.
results Positive, negative and doubtful attitudes towards 
AS were observed in 347 (33%), 331 (31%) and 381 (36%) 
patients, respectively. Female patients were more likely to 
report a negative attitude towards AS (38.7% vs 29.6%, 
p=0.04) while patients with previous parenthood more 
frequently reported a positive opinion on AS (37.2% vs 29.9%, 
p=0.005). Patient age emerged as the only predictor of a 
positive attitude towards AS (OR 1.03; 95% CI 1.01 to 1.04, 
p<0.001), with a 46% and 33% probability of being pro-AS for 
a patient aged 65 and 45 years, respectively.
Conclusions One out of three patients would express 
positive feedbacks on AS in the unfortunate case of tumour 
diagnosis, only according to his/her baseline personal opinion 
and prior to any discussion with a cancer caregiver. The older 
the patient, the higher the probability of being compliant with 
a conservative management for cancer.
IntrODuCtIOn 
The National Cancer Institutes dictionary 
of cancer terms defines active surveillance 
(AS) as a treatment plan involving a close 
watching of patient’s condition based on 
regular examinations and tests, without 
giving any active treatment unless there are 
changes in tests results demonstrating a 
worsening of the condition.1 This relatively 
novel attitude to approach and treat a patient 
gained increasing importance in the uro-on-
cological field throughout the last decades2–4; 
indeed, AS has emerged as a valid alternative 
to radical approaches for men with low-risk 
disease.5 6 Overall, patients with low-risk pros-
tate cancer (PCa) currently managed with 
AS have been reported to range between 
10% and 55%.5 6 Likewise, AS for small renal 
masses is suggested as an available options by 
international clinical guidelines,3 7 although 
remains an uncommon practice, with data 
showing that only 9%–10% of cT1a kidney 
cancer (KC) patients have been managed 
with AS in the last two decades.3 7 
The rationale behind AS comes from the 
purpose to reduce the morbidity burden often 
associated with a potential overtreatment in 
subjects harbouring an indolent disease8; 
conversely, from their point of view, patients 
may consider irrational and dangerous not to 
treat a cancer, thus preferring a radical treat-
ment to AS.9
Numerous published surveys addressed 
the psychological aspects related to patients’ 
acceptance and compliance to surveillance 
protocols for the primary management of 
cancer9–14; psychological aspects including 
strengths and limitations of this study
 ► Patients completed the survey before any interaction 
with a caregiver, thus providing unbiased informa-
tion about their opinion on active surveillance (AS).
 ► We used a non-validated questionnaire to assess 
patients’ opinion on AS, although the survey was 
developed with an expert in sociology and human 
behaviour.
 ► The majority of patients were not assessed for 
cancer.
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anxiety, distress, expectations and patients’ personal atti-
tude towards treatment options emerged to play a signif-
icant role over the decision-making process for cancer 
treatment.9 12 Available data on the psychosocial factors 
associated with patients’ adherence to AS mainly come 
from self-selected cohorts of individuals already enrolled 
in AS protocols,12 13 15 that could have been influenced 
by both their personal experience and the interaction 
with a caregiver. Indeed, also caregivers have a major 
impact on patients’ final decision regarding cancer treat-
ment modalities.15 16 Similarly, patients may have great 
concerns about the possibility to receive unbiased treat-
ment recommendations.17
In order to provide data on the unbiased ‘baseline’ 
patients’ perspective on AS as the primary treatment 
modality, we assessed a cohort of patients referring for 
the first time to the outpatient clinic of an academic 
centre for either benign or malignant uroandrological 
disorders, investigating their attitude towards the idea of 
AS in the unfortunate case of tumour diagnosis.
MethODs
The analyses were based on a cohort of 2069 consecutive 
patients (aged ≥18 years) at their first access to a tertia-
ry-referral outpatient clinic for uroandrological purposes 
from January 2014 to December 2016.
Participants were invited to complete anonymously an 
8-item self-administered questionnaire with closed ques-
tions (online supplementary appendix 1). The question-
naire was developed in collaboration with an expert in 
sociology and human behaviour (IC).
As a prerequisite for entry, all participants were asked 
if they either regularly or at least occasionally surf the 
internet. In this context, terms and definitions that were 
used throughout the study have been taken from the 
internet, mainly considering blogs and forums for patients 
in order to consider terminology which could be readable 
and understandable for people who were not specifically 
in the medical field. To this aim, the concept of AS was not 
extensively explained prior to the survey compilation.
The survey included sections assessing sociodemographic 
aspects (questions 1–5 in online supplementary appendix 
1) and their primary reason for the office visit (question 
6, online supplementary appendix 1). The attitude towards 
AS was investigated with a closed question (questions 7, 
online supplementary appendix 1): patients were asked 
whether, in the case of cancer diagnosis (for instance, pros-
tate or kidney cancers), they would be willing to follow up 
the disease with examinations (including invasive tests, 
such as biopsy) over time, without treating it radically 
and immediately. Conversely, question 8 requested partic-
ipants to subjectively score, with a 10-point Likert scale, 
the importance they would give to different aspects of life 
(thus including survival, partner and relationship, social 
life, personal belongings, sexual life, urinary continence 
and body image) in the same unfortunate case of tumour 
diagnosis.
Patients who refused to participate to the survey 
(n=831) and those who provided incomplete question-
naires (n=228) were excluded from the analyses. There-
fore, the final analysis considered a valid cohort of 1059 
patients, reflecting a 51% response rate.
Data collection followed the principles outlined in the 
Declaration of Helsinki. 
Patient and public involvement
Patients were not involved in the design and the develop-
ment of the study.
statistical analyses
The aim of the study was to assess the rate of patients 
reporting a positive attitude towards AS in a ‘baseline’ 
scenario. The association between patients sociodemo-
graphic characteristics and personal opinion on AS was 
also investigated; the statistical significance of differences 
between continuous and categorical variables was tested 
with the Wilcoxon rank-sum test, the one-way analysis of 
variance and Pearson χ2 test, accordingly.
Logistic regression analysis was used to test predic-
tors of the attitude towards AS which was considered 
as a binary outcome (negative/doubtful vs positive). 
The adjusted probability of choosing AS was plotted on 
patient’s age.
Statistical tests were performed using STATA V.13. All 
tests were two sided, with a significance level set at 0.05.
Table 1 Sociodemographic characteristics of the entire 
cohort (n=1059)
Age, median (IQR) 40 (33–55)
Gender, n (%)
  Male 868 (82)
  Female 191 (18)
Education status, n (%)
  LL 114 (11)
  HL 945 (89)
Stable relationship, n (%) 909 (86)
Previous parenthood, n (%)
  Yes 414 (39)
  No 645 (61)
Primary reason for office visit, n (%)
  Couple infertility 295 (28)
  Sexual dysfunction 212 (20)
  LUTS 227 (21)
  Urinary incontinence 8 (0.8)
  rUTIs 75 (7.1)
  Urological cancer 53 (5)
  Other/uroandrological check-up 189 (18)
HL, high educational level; LL, low educational level; LUTS, 
lower urinary tract symptoms; rUTIs, recurrent urinary tract 
infections.
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Table 2 Participants’ personal attitudes towards active surveillance (AS) management
Question 7—online supplementary appendix 1
AS
No I don’t know Yes P values*
Overall no, n (%) 331 (31) 381 (36) 347 (33) –
Age, median (IQR) 40 (33–54) 39 (32–50) 45 (35–59) <0.0001
Gender, n (%)
  Male 257 (29.6) 319 (36.7) 292 (33.6) 0.04
  Female 74 (38.7) 62 (32.4) 55 (28.8)
Education status, n (%)
  LL 38 (33.3) 42 (36.8) 34 (29.8) 0.8
  HL 293 (31) 339 (35.8) 313 (33.1)
Stable relationship 293 (32.2) 320 (35.2) 296 (32.5) 0.2
Previous parenthood, n (%)
  Yes 135 (32.6) 125 (30.1) 154 (37.2) 0.005
  No 196 (30.3) 256 (39.6) 193 (29.9)
Primary reason for office visit, n (%)
  Couple infertility 96 (32.5) 110 (37.2) 89 (30.1) 0.4
  Sexual dysfunction 63 (29.7) 82 (38.6) 67 (31.6)
  LUTS 78 (34.3) 76 (33.4) 73 (32.1)
  Urinary incontinence 4 (50) 1 (12.5) 3 (37.5)
  rUTIs 20 (26.6) 30 (40) 25 (33.3)
  Urological cancer 14 (26.4) 13 (24.5) 26 (49.1)
  Other/uroandrological check-up 56 (29.6) 69 (36.5) 64 (33.8)
*P values according to the Pearson's Χ2 and Kruskal-Wallis test.
HL, high educational level; LL, low educational level; LUTS, lower urinary tract symptoms; rUTIs, recurrent urinary tract infections.
Table 3 Subjective importance given to personal life aspects according to different opinions towards active surveillance (AS) 
among male and female patients
Question 8—online supplementary appendix 1
If you were diagnosed with cancer, how much importance would you give to different aspects of personal 
life?
(Rate from 0=none to 10=highest importance)
Means (SD)
Overall
Male attitude towards AS
P values*
Female attitude towards AS
P values*Negative Doubtful Positive Negative Doubtful Positive
Survival 9.4 (1.5) 9.5 (1.3) 9.4 (1.6) 9.3 (1.7) 0.7 9.5 (1.3) 9.4 (1.6) 9.3 (1.7) 0.2
Partner 8.8 (2.0) 8.9 (1.8) 8.7 (1.9) 8.9 (2.0) 0.2 8.9 (1.8) 8.7 (1.9) 8.9 (2.0) 0.1
Friends and 
relatives
6.6 (2.8) 6.5 (2.9) 6.4 (2.8) 6.9 (2.7) 0.1 6.5 (2.9) 6.4 (2.8) 6.9 (2.7) 0.1
Social life 5.8 (2.8) 5.7 (2.9) 5.6 (2.9) 6.2 (2.7) 0.04 5.7 (2.9) 5.6 (2.9) 6.2 (2.7) 0.02
Personal 
belongings
4.5 (3.1) 4.6 (3.1) 4.3 (3.1) 4.6 (3.3) 0.6 4.6 (3.1) 4.3 (3.1) 4.6 (3.3) 0.1
Sexual life 6.6 (2.8) 6.5 (2.8) 6.6 (2.7) 6.8 (2.8) 0.4 6.5 (2.8) 6.6 (2.7) 6.8 (2.8) 0.3
Urinary 
continence
7.1 (2.8) 7.3 (2.9) 6.9 (2.8) 7.1 (2.8) 0.7 7.3 (2.9) 6.9 (2.8) 7.1 (2.8) 0.3
Body image 6.4 (2.9) 6.7 (2.8) 6.4 (2.8) 6.2 (3.0) 0.8 6.7 (2.8) 6.4 (2.8) 6.2 (3.0) 0.1
*Significance for differences within groups according to one-way analysis of variance test.
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results
The sociodemographic characteristics of the entire cohort 
are reported in table 1; median age of participants was 
40 years (IQR: 33–55). Main primary reasons for office 
evaluation were lower urinary tract symptoms (LUTS) in 
21% (227) of cases and couple infertility reported by 28% 
(295) of cases. Of note, only 5% (53) of the whole cohort 
presented for cancer evaluation.
Overall, 33% (347) of the participants expressed a posi-
tive attitude towards AS (table 2). Patients with a positive 
feeling towards AS were significantly older compared with 
the others (table 2). Moreover, female patients were more 
likely to report a negative attitude towards conservative 
management for cancer as compared with male individ-
uals (38.7% vs 29.6%, p=0.04), while those with previous 
parenthood more frequently reported a positive opinion 
on AS (37.2% vs 29.9%, p=0.005) (table 2). Patients 
presenting for cancer evaluation did not report different 
attitudes towards AS compared with those presenting for 
non-oncological purposes (table 2).
Table 3 depicts self-reported scores given to the different 
aspects of life, after the hypothetical case of diagnosis of a 
cancer, according to gender. Overall, all patients attributed 
the highest importance to survival. No significant difference 
has been observed in terms of patients attitude towards AS 
for each category, but for social life to which both male and 
female patients with positive attitude to AS has been given 
greater importance (p<0.04).
At multivariable logistic regression analyses, age was posi-
tively associated with being pro-AS (OR 1.03, 95% CI 1.01 to 
1.04, p<0.001), after adjusting for other sociodemographic 
characteristics (table 4). Figure 1 shows the adjusted prob-
ability of reporting a positive attitude towards AS according 
to patients’ age; for those aged 65 years old, the probability 
of complying with AS for cancer management was 46% 
compared with 33% for patients aged 45 years.
DIsCussIOn
We looked at the attitude towards AS among patients at 
their first clinical assessment for uroandrological disor-
ders. We showed that one-third of them would choose AS 
management in the hypothetical unfortunate scenario of 
being diagnosed with a urological cancer, exclusively on 
the basis of their subjective opinion and without a previous 
discussion with a dedicated cancer caregiver. Female 
patients were less likely to be pro-AS for cancer manage-
ment, while patients with children reported a positive atti-
tude towards AS in a higher number of cases. Of note, 
patients age resulted as the only significant predictor 
of being pro-AS after accounting for other sociodemo-
graphic characteristics: older patients were significantly 
more likely to comply with AS in case of cancer diagnosis.
Patient’s perspective and preferences play a major role 
over the cancer treatment decision-making process.8 
Previous surveys assessed patients’ preference towards 
different PCa treatments prior to the final therapeutic deci-
sion.9–11 Zeliadt et al, for instance, reported a 15% rate of 
PCa patients willing to follow a watchful waiting approach 
mainly because of a number of concerns about the physical 
burden associated with active treatments.10 Moreover, de 
Bekker-Grob et al investigated treatment preferences in 110 
patients undergoing biopsy for a suspicion of PCa, before 
communicating the final diagnosis; they reported that up to 
76% of patients without anxiety/depression would choose 
AS.9 A common limitation of both previous studies was 
patients’ direct involvement with having PCa, and the poten-
tial concomitant impact of a discussion with their caregivers 
on the same topic. In our study, we provided novel findings 
by assessing the opinion on cancer surveillance in a cohort 
of patients that never discussed the issue of curative treat-
ments or AS with any caregiver, and who mostly were seeking 
medical help for benign disorders, thus providing a sort of 
‘baseline’ attitude of uroandrological patients towards living 
with an indolent cancer; our findings suggest that about 30% 
of patients would be willing to choose a surveillance manage-
ment in case of cancer diagnosis, even before discussing the 
harms and benefit of this approach with a physician.
The relevant influence of a caregiver throughout the 
oncological decision-making process has been previously 
Table 4 Logistic regression analysis predicting positive 
attitude towards active surveillance
OR (95% CI) P values
Age 1.03 (1.01 to 1.04) <0.0001
Gender 
(Male vs female)
1.00 (0.69 to 1.43) 1
Education level
(LL vs HL)
1.45 (0.93 to 2.26) 0.1
Stable marital relationship 0.77 (0.52 to 1.13) 0.2
Previous parenthood 0.84 (0.58 to 1.21) 0.3
Primary reason for office 
evaluation
(Other (any type) vs cancer)
1.59 (0.88 to 2.85) 0.1
HL, high educational level; LL, low educational level.
Figure 1 Adjusted probability of reporting a positive attitude 
towards active surveillance (AS) according to patients’ age 
(dashed lines indicate the 95% CI values).
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reported15 16 18; in this context, adequate communication 
and patient education have been shown to have a posi-
tive effect in reducing anxiety and uncertainty related to 
therapeutic decisions.18 Recently, Ehdaie et al16 reported 
that a systematic approach for counselling PCa patients 
regarding AS led to an increase in terms of AS accep-
tance from 69% to 81% of cases. This would support our 
findings showing a 36% of patients doubting about being 
either pro or con AS, though not rejecting a priori the 
idea of choosing AS to finally manage their cancer.
The reasons behind patients’ treatment preferences have 
been previously investigated; Hoffman et al reported that in 
a cohort of 934 men with PCa, almost 30% of those who had 
receive either surgery or radiotherapy eventually expressed 
treatment decision regret due to worse bowel and sexual 
outcomes.19 Previous data showed that the desire for cancer 
eradication is greater in younger patients,20 despite young 
persons could be also more prone to attempt and avoid func-
tional side effects (ie, sexual dysfunction and urinary incon-
tinence in the case of PCa) potentially associated with active 
treatment.21 22 In a cohort of 986 men below the age of 50 
years and a diagnosis of low risk PCa, Sidana et al reported 
that surgery and AS were the preferred type of treatment in 
81.4% and 5.3% of cases, respectively; moreover, physicians 
recommended against AS in more than 75% of cases.20 In 
our series, we observed that patients who would choose AS 
were more likely to give high importance to social life in 
the case of cancer diagnosis; these results may be related 
to the fear for potential drawbacks associated with radical 
treatments that could impair the social life of the subject. 
Moreover, in line with previous data, we observed that the 
older the patient the higher the probability of reporting a 
positive attitude towards AS, regardless both their educa-
tional and family status; the odds of accepting either AS 
could be roughly 30% in a 45-year-old patient, while they 
increased up to 46% for a patient aged 65 years. These 
results encourage physicians to comprehensively discuss 
cancer surveillance with younger patients who might be less 
inclined to accept this type of management, thus stressing 
the importance of a proper counselling aimed to improve 
the value of patients understanding and consciousness 
about treatment options, by giving a reliable estimation of 
the risks and side effects associated with both surveillance 
protocols and active treatments, both in oncological and 
functional terms. In this context, to further stress the rele-
vance of a fruitful interaction with the patients, every physi-
cian should provide the outcomes of the treating centre 
along with those published across the scientific literature, 
thus to limiting and avoid false expectations.
This study is not devoid of limitations. First, we used 
a non-validated questionnaire to assess patients’ opinion 
on AS. However, to the best of our knowledge, there are 
no currently available questionnaires specifically inves-
tigating all the aspects we have tried to assess. Second, 
although we obtained virtually ‘unbiased’ baseline opin-
ions on AS of a homogenous cohort of uroandrological 
patients, more than one-third of the whole sample under-
went primary evaluation for andrological conditions, 
thus raising the suspicion to pay more attention to quali-
ty-of-life issues than a population of oncological patients. 
To control for this specific bias, we analysed data from 
patients with a diagnosis of cancer within our cohort 
without finding any difference in terms of attitudes 
towards AS compared with non-cancer patients; more-
over, seeking medical help for cancer was not associated 
with a specific attitude towards AS at multivariable anal-
yses. Third, mean age in our setting was relatively lower 
compared with the usual age of PCa and KC popula-
tions; this aspect may even strengthen our results since 
we provided novel findings about patients’ opinion on 
AS in a relatively young population, thus encouraging 
physicians to discuss surveillance management even in 
younger patients with cancer diagnosis in the everyday 
clinical setting. Fourth, given the specific nature of the 
enrolled population (ie, patients seeking medical help at 
an uroandrological outpatient clinic), we were not able 
to balance our cohort according to gender. However, a 
20% of female subjects participated to the survey and we 
observed a significant difference in the opinion towards 
AS according to gender, thus suggesting that an adequate 
number of female patients had been included in the 
study. Fifth, we observed a relatively high rate of patients 
who refused to complete the survey, thus potentially intro-
ducing a further selection bias; however, we did not find 
any difference in terms of sociodemographic characteris-
tics between patients who complete and those who did not 
complete the survey at a sensitivity analysis (all p>0.05). 
Last, we lack any specific tool to evaluate psychological 
distress almost inevitably associated with being diagnosed 
with a cancer, and even more relevant with a cancer for 
which available therapies are potentially associated with a 
number of persistent complications interfering with both 
sexual and urinary functions.
COnClusIOns
We provided novel evidence that about one-third of 
patients would opt for AS in the unfortunate case of 
tumour diagnosis before any interaction with a cancer 
caregiver, with as many as one-third of the questioned 
patients sample completely doubtful about the choice. 
Of clinical relevance, the older the patient, the higher 
the probability of choosing a conservative management 
for cancer. Physicians should be encouraged to keep 
suggesting AS to old patients when clinically appropriate 
and to comprehensively discuss the adequacy of a conser-
vative cancer management with younger individuals to 
improve their subjective acceptability, and the conse-
quent compliance, towards this type of treatment.
Contributors PC and AS conceived and designed the study. LB, WC, RS and FC 
collected the data. IC and AS developed the questionnaire. PC and EV conducted the 
analysis. FM, AB and AS critically revised the manuscript for important intellectual 
content. All authors approved the final version prior to submission.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors. 
 o
n
 30 Novem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022495 on 29 August 2018. Downloaded from 
6 Capogrosso P, et al. BMJ Open 2018;8:e022495. doi:10.1136/bmjopen-2018-022495
Open access 
Competing interests None declared.
Patient consent Obtained.
ethics approval IRCCS Ospedale San Raffaele.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The authors’ licence for using these data precludes the 
sharing of raw data with third parties.
Open access This is an open access article distributed in accordance with 
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this work 
non-commercially, and license their derivative works on different terms, 
provided the original work is properly cited, appropriate credit is given, 
any changes made indicated, and the use is non-commercial. See: http:// 
creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. National Cancer Institutes.. Dictionary of cancer terms;. https://www. 
cancer. gov/ publications/ dictionaries/ cancer- terms? cdrid= 616060.
 2. Ritch CR, Graves AJ, Keegan KA, et al. Increasing use of observation 
among men at low risk for prostate cancer mortality. J Urol 
2015;193:801–6.
 3. Huang WC, Atoria CL, Bjurlin M, et al. Management of small kidney 
cancers in the new millennium: contemporary trends and outcomes 
in a population-based cohort. JAMA Surg 2015;150:664–72.
 4. Cooperberg MR, Broering JM, Carroll PR. Time trends and local 
variation in primary treatment of localized prostate cancer. J Clin 
Oncol 2010;28:1117–23.
 5. Hamdy FC, Donovan JL, Lane JA, et al. 10-year outcomes after 
monitoring, surgery, or radiotherapy for localized prostate cancer. N 
Engl J Med 2016;375:1415–24.
 6. Cooperberg MR, Carroll PR. Trends in management for patients with 
localized prostate cancer, 1990-2013. JAMA 2015;314:80–2.
 7. Drangsholt S, Huang WC. Current trends in renal surgery 
and observation for small renal masses. Urol Clin North Am 
2017;44:169–78.
 8. Dall'Era MA. Patient and disease factors affecting the choice and 
adherence to active surveillance. Curr Opin Urol 2015;25:272–6.
 9. de Bekker-Grob EW, Bliemer MC, Donkers B, et al. Patients' and 
urologists' preferences for prostate cancer treatment: a discrete 
choice experiment. Br J Cancer 2013;109:633–40.
 10. Zeliadt SB, Moinpour CM, Blough DK, et al. Preliminary treatment 
considerations among men with newly diagnosed prostate cancer. 
Am J Manag Care 2010;16:e121–30.
 11. Xu J, Dailey RK, Eggly S, et al. Men's perspectives on selecting their 
prostate cancer treatment. J Natl Med Assoc 2011;103:468–79.
 12. van den Bergh RC, Essink-Bot ML, Roobol MJ, et al. Anxiety and 
distress during active surveillance for early prostate cancer. Cancer 
2009;115:3868–78.
 13. van Vugt HA, Roobol MJ, van der Poel HG, et al. Selecting men 
diagnosed with prostate cancer for active surveillance using a risk 
calculator: a prospective impact study. BJU Int 2012;110:180–7.
 14. Hoffman RM, Van Den Eeden SK, Davis KM, et al. Decision-making 
processes among men with low-risk prostate cancer: a survey study. 
Psychooncology 2018;27.
 15. Gorin MA, Soloway CT, Eldefrawy A, et al. Factors that influence 
patient enrollment in active surveillance for low-risk prostate cancer. 
Urology 2011;77:588–91.
 16. Ehdaie B, Assel M, Benfante N, et al. A systematic approach to 
discussing active surveillance with patients with low-risk prostate 
cancer. Eur Urol 2017;71:866–71.
 17. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following 
conservative management of clinically localized prostate cancer. 
JAMA 2005;293:2095–101.
 18. Pickles T, Ruether JD, Weir L, et al. Psychosocial barriers to active 
surveillance for the management of early prostate cancer and a 
strategy for increased acceptance. BJU Int 2007;100:544–51.
 19. Hoffman RM, Lo M, Clark JA, et al. Treatment decision regret among 
long-term survivors of localized prostate cancer: results from the 
prostate cancer outcomes study. J Clin Oncol 2017;35:2306–14.
 20. Sidana A, Hernandez DJ, Feng Z, et al. Treatment decision-making 
for localized prostate cancer: what younger men choose and why. 
Prostate 2012;72:58–64.
 21. Tavlarides AM, Ames SC, Diehl NN, et al. Evaluation of the 
association of prostate cancer-specific anxiety with sexual function, 
depression and cancer aggressiveness in men 1 year following 
surgical treatment for localized prostate cancer. Psychooncology 
2013;22:1328–35.
 22. Salonia A, Adaikan G, Buvat J, et al. Sexual Rehabilitation After 
Treatment for Prostate Cancer-Part 1: Recommendations From the 
Fourth International Consultation for Sexual Medicine (ICSM 2015). J 
Sex Med 2017;14:285–96.
 o
n
 30 Novem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022495 on 29 August 2018. Downloaded from 
